Literature DB >> 18589361

Autologous breast reconstruction: the Vanderbilt experience (1998 to 2005) of independent predictors of displeasing outcomes.

Joseph A Greco1, Eric T Castaldo, Lillian B Nanney, Y-C Wu, Rafe Donahue, J Jason Wendel, Kevin F Hagan, R Bruce Shack.   

Abstract

BACKGROUND: Optimal surgical outcomes are dependent on an appreciation of comorbid conditions that may handicap results. The purpose of this retrospective analysis was to delineate risk factors for complications after autologous breast reconstruction. STUDY
DESIGN: An institutional database was constructed of patients who underwent autologous breast reconstruction from 1998 to 2005. Variables captured included age, diabetes and smoking status, prereconstruction radiation therapy, concomitant breast resection, preoperative albumin, flap type, and body mass index (BMI; based on World Health Organization classifications: BMI>25, overweight; >30, obese). The primary outcome was noninfectious wound complications (NIWC), a novel classification based on the extent of tissue derangement and need for operative intervention. Secondary outcomes were wound infection, hematoma, hernia, and fat necrosis. Statistical analysis was performed using chi-square tests and multiple logistic regression.
RESULTS: The analysis included 200 flaps (transverse rectus abdominis myocutaneous [TRAM]=171; latissimus dorsi=29) in 180 patients. There were 19 infections (9.5%), 3 total flap losses (1.5%), 14 hematomas (7%), and 11 donor-site hernias (6%). The incidences of fat necrosis and any NIWC were 18% and 36%, respectively. Mean followup was 13.1 months (range 1.1 to 51.7 months). Multiple logistic regression demonstrated that obesity (BMI>30) is a statistically significant independent risk factor for any NIWC (hazards ratio=6.58; 95% CI, 2.85 to 15.18; p < 0.01) and for NIWC requiring operative treatment (NIWC>or=3; hazard ratio=6.23; 95% CI 2.15 to 18.05; p < 0.01). Increased BMI predicts NIWC, NIWC requiring operative intervention, and wound infection (p < 0.01).
CONCLUSIONS: These data suggest that obesity is a strong predictor of simple and complex NIWC and of wound infection after autologous breast reconstruction. Obese patients should be counseled about their significantly increased risk of experiencing these unwanted outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18589361     DOI: 10.1016/j.jamcollsurg.2007.12.052

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Obesity Should Not Prevent from TRAM Flap Breast Reconstruction in Developing Countries.

Authors:  Sadaf Alipour; Ramesh Omranipour; Rahim Akrami
Journal:  Indian J Surg       Date:  2013-01-31       Impact factor: 0.656

2.  The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer.

Authors:  Philip M Spanheimer; Jennifer C Carr; Alexandra Thomas; Sonia L Sugg; Carol E H Scott-Conner; Junlin Liao; Ronald J Weigel
Journal:  Am J Surg       Date:  2013-01-31       Impact factor: 2.565

Review 3.  Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review.

Authors:  Clara Lee; Christine Sunu; Michael Pignone
Journal:  J Am Coll Surg       Date:  2009-04-24       Impact factor: 6.113

4.  An Innovative Risk-Reducing Approach to Postmastectomy Radiation Delivery after Autologous Breast Reconstruction.

Authors:  Merisa L Piper; Maristella Evangelista; Dominic Amara; David Daar; Robert D Foster; Barbara Fowble; Hani Sbitany
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-04-25

5.  Patient's Education Before Mastectomy Influences the Rate of Reconstructive Surgery.

Authors:  R Tarkowski; K Szmigiel; A Rubin; G Borowiec; J Szelachowska; W Jagodziński; M Bębenek
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

6.  Age and Overweight Are Not Contraindications for a Breast Reconstruction with a TMG-Flap-A Risk and Complication Analysis of a Retrospective Double Center Study Including 300 Patients.

Authors:  Karl Schwaiger; Laurenz Weitgasser; Maximilian Mahrhofer; Kathrin Bachleitner; Selim Abed; Julia Wimbauer; Elisabeth Russe; Thomas Schoeller; Gottfried Wechselberger
Journal:  J Clin Med       Date:  2021-03-01       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.